Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1985-11-15
|
pubmed:abstractText |
A human monoclonal antibody, P3D9 (IgG2, lambda type), that bound to Pseudomonas aeruginosa Homma serotype 5 cells with high specificity was produced by cell fusion between a human tonsillar lymphocyte and a mouse plasmacytoma cell, P3-X63-Ag8-U1 (P3U1). The yield of P3D9 secreted into the culture supernatant from the mouse-human hybridoma was 2-10 micrograms/ml, and this hybridoma cell line has been stably producing this antibody for six months. Antibody P3D9 alone did not cause agglutination of serotype 5 cells, but the cells were agglutinated after addition of goat antibody to human IgG. Antibody P3D9 was proven to have protective activity against infection with P. aeruginosa, and the 50% protective dose estimated for experimental peritoneal infection with P. aeruginosa was 2.4 micrograms per mouse.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-1899
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
152
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
965-70
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3930629-Agglutination Tests,
pubmed-meshheading:3930629-Animals,
pubmed-meshheading:3930629-Antibodies, Bacterial,
pubmed-meshheading:3930629-Antibodies, Monoclonal,
pubmed-meshheading:3930629-Antibody Specificity,
pubmed-meshheading:3930629-Humans,
pubmed-meshheading:3930629-Hybridomas,
pubmed-meshheading:3930629-Lipopolysaccharides,
pubmed-meshheading:3930629-Mice,
pubmed-meshheading:3930629-Pseudomonas Infections,
pubmed-meshheading:3930629-Pseudomonas aeruginosa,
pubmed-meshheading:3930629-Serotyping
|
pubmed:year |
1985
|
pubmed:articleTitle |
Characterization of a human monoclonal antibody to lipopolysaccharides of Pseudomonas aeruginosa serotype 5: a possible candidate as an immunotherapeutic agent for infections with P. aeruginosa.
|
pubmed:publicationType |
Journal Article
|